Larry Dobrow

Most Recent Articles by Larry Dobrow

Five things for pharma marketers to know: Thursday, February 8, 2018

Five things for pharma marketers to know: Thursday, February 8, 2018

By

FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

By

Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received warmly when it was made public last October.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

By

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

By

Four data aces share their backgrounds, inspirations, and guiding philosophies

Five things for pharma marketers to know: Monday, January 29, 2018

Five things for pharma marketers to know: Monday, January 29, 2018

By

Outcome Health settles fraud allegations, reassigns leaders; Approval of generics surges during first year of Trump administration; Sanofi acquires coveted biotech firm.

More Articles by Larry Dobrow